Impact of Fatty Stimuli on Cerebral Activity in Anorexia Nervosa: a Multi-sensory Approach

NCT ID: NCT07344831

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2027-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lipid restriction is significant in anorexia nervosa and limits therapeutic management. The multisensory perception of fat is altered, creating an aversion to lipids. The investigators aim to characterize the impact of sensory stimulation (smells or images) associated with specific tastes using neuropsychological assessments and functional MRI. Some volatile aromas can enhance the perception of the associated taste. The investigators hypothesize that such associations are altered in anorexia nervosa for fatty foods but may be preserved for sweet tastes, and that this alteration contributes to the maintenance of the disease. The interdependence of different sensory perceptions of lipids could play a major role in the therapeutic approach, aiding in the deconditioning of this aversion and the restoration of positive food sensory associations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anorexia Nervosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anorexia Nervosa patient group

30 patients with anorexia nervosa

Group Type EXPERIMENTAL

MRI examination

Intervention Type OTHER

One hour MRI examination

Smell and taste capacity testings

Intervention Type OTHER

one hour sensory testings

Normal Weight Control group

30 control subjects of normal weight

Group Type ACTIVE_COMPARATOR

MRI examination

Intervention Type OTHER

One hour MRI examination

Smell and taste capacity testings

Intervention Type OTHER

one hour sensory testings

Low Weight Control group

30 control subjects with a similar weight to AN patients (the constitutional thinness group)

Group Type ACTIVE_COMPARATOR

MRI examination

Intervention Type OTHER

One hour MRI examination

Smell and taste capacity testings

Intervention Type OTHER

one hour sensory testings

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI examination

One hour MRI examination

Intervention Type OTHER

Smell and taste capacity testings

one hour sensory testings

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person affiliated or entitled to a social security scheme
* Person having received informed information on the study and having co-signed, with the investigator, a consent to participate in the study
* female person
* Person affiliated or entitled to a social security scheme
* Over 18 years'old
* Knowing how to read and write French
* Patient diagnosed with anorexia nervosa according to DSM-5 criteria for at least 5 years (HAS criteria). Failure of prior outpatient or/and hospitalization care over the last 12 months: stable or falling low BMI, unmodified food restriction, continued fear of weight gain, disturbances in the perception of body image
* BMI \< 18.5 kg/m² for volunteers in a state of constitutional thinness. The absence of eating disorder and the absence of restriction to DEBQ questionnaires. Fertility preserved.
* For volunteers of normal weight: 18.5 kg/m² \< BMI \< 25 kg/m²

Exclusion Criteria

* Pregnant women, parturient, nursing mothers;
* Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than research;
* Minors
* Refusal of the study by the participant
* Person incapable of giving informed consent
* Artificial nutrition
* Associated organic damage favoring undernutrition: other chronic diseases (digestive, infectious, endocrine, pulmonary, cardiac, neurological), neoplasms, etc.
* Abuse of psychoactive substances except tobacco
* Characterized depressive episode, psychosis
* Score less than 14 on the Edinburgh laterality questionnaire.
* Contraindications to MRI or allergy to one of the components of the olfactory and taste tests
* Smokers
* Smell or taste alterations
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Saint-Etienne

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fabien SCHNEIDER, MD

Role: CONTACT

(0)477127529 ext. +33

Florence RANCON, CDP

Role: CONTACT

(0)477829458 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fabien SCHNEIDER, MD

Role: primary

(0)477127529 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANSM

Identifier Type: OTHER

Identifier Source: secondary_id

24CH172

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.